1-year outcomes of single bolus r-SAK before primary PCI for STEMI: The follow-up of OPTIMA-5
{{output}}
The OPTIMA-5 study demonstrated that a single bolus of half-dose recombinant staphylokinase (r-SAK) before primary percutaneous coronary intervention (PCI) significantly improved the patency of infarct related artery in patients with ST-elevation myocardial in... ...
